Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c. Swiss Medical Weekly, [S. l.], v. 133, n. 3334, p. 455–460, 2003. DOI: 10.4414/smw.2003.10300. Disponível em: https://smw.ch/index.php/smw/article/view/299. Acesso em: 5 nov. 2025.